Sponsor Pipeline

Maia Biotechnology Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
1
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 3
1
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06908304 A Phase III Study With THIO + Cemiplimab vs Chemotherapy as 3rd Line Treatment in… Carcinoma, Non-Small -Cell Lung Recruiting
Phase 2
NCT05208944 THIO Sequenced With Cemiplimab in Advanced NSCLC Carcinoma, Non-Small-Cell Lung Active, Not Recruiting
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (1)
Get alerts when Maia Biotechnology's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free